NEW YORK (GenomeWeb News) - Fluidigm said today that it has taken co-exclusive licenses to intellectual property developed at Stanford University for detecting fetal genetic characteristics in maternal plasma, including the use of a combination of digital PCR and high-throughput sequencing for that application.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.